IFNG and colorectal carcinoma: The aim of this study was to elucidate the molecular mechanisms through which IFNγ alters HLA-I peptide presentation by comparing the immunopeptidome of untreated and 48-hour IFNγ-treated colorectal cancer PDOs (CRC-01, CRC-04, CRC-05).